Bioxcel Therapeutics Inc

This study tested a new drug, BXCL701, taken as a pill, together with the immunotherapy pembrolizumab in men with advanced prostate cancer that has stopped responding to hormone therapy. The goal was to find the best dose and see if the combination could shrink tumors or slow the…

This study tested a medicine called BXCL501 for calming sudden episodes of agitation in people with dementia. 151 participants took the medicine or a placebo as needed over 12 weeks. The goal was to see if the medicine safely reduces agitation symptoms like tension and hostility.

This study tested an investigational medication called BXCL501 for calming agitation episodes in people with bipolar disorder, schizophrenia, or related conditions. 452 participants received either the drug or a placebo, and researchers measured changes in agitation levels and sa…

This study looked at how the body builds tolerance to Igalmi (a fast-acting medicine for agitation) and what happens when it's stopped. It involved 29 adults with schizophrenia or bipolar disorder who had frequent agitation. Researchers measured changes in agitation levels and wa…

This study looked at whether family members or caregivers can help measure agitation in people with bipolar disorder or schizophrenia. 33 adults took a single dose of an experimental medicine, and researchers compared ratings from doctors, patients, and their family members. The …